Raising Capital | Using Debt versus Equity Financing for early-stage Biotech and Life Sciences companies

At a time when raising capital may be challenging, Life Sciences and Biotech startups & early-growth stage companies should evaluate debt financing, a form of capital that is more traditionally used by early-stage tech companies or companies generating steady streams of cash flows.   During a panel discussion with our seasoned experts, we will reflect on:

• Is debt financing the right instrument to grow your biotech or life sciences company?
• When should life sciences/biotech startups and early-growth stage companies consider debt financing?
• What are the pros and cons of raising debt versus equity?
• What financing structures are available?

The panel discussion will be preceded by a tour of the Smartlabs facilities at Boston Landing: Join us at 5pm to learn how they deliver flexible turnkey lab programs to support workflows at every stage of development.

This event is supported by KeyBank.

Date: Tuesday, April 9, 2024
Time:

• 5 pm – Private tour of SmartLabs state-of-the-art facilities
• 6 pm – Panel Discussion, followed by networking cocktail

Location: Smartlabs, (3rd floor) 40 Guest St, 02135, Boston, (directions), onsite parking available (access behind the building)
Registration:  $32 for GABC members | $47 for non-members

This event is organized by FACCNE. Please use their registration link to register. Select “GABC member” when checking out to receive the member price.